Jing H.

Jing H. is a Senior Director of External Innovations at BioNTech SE since April 2024, overseeing external innovations and reporting to Ugur. Prior experience includes serving as an Analyst in Therapeutics at Casdin Capital from 2021 to 2024, and as a Portfolio Manager and Biotech Equity Research Analyst at GAMCO Investors from 2015 to 2021. Jing H. also held positions as a Summer Senior Research Associate at Sanford C. Bernstein, a Summer Associate at Leerink Partners, and a Research Associate II at Regeneron Pharmaceuticals. Educational qualifications include an MBA from Columbia Business School and a Master's in Chemistry from Washington University in St. Louis, as well as a Bachelor's in Chemistry from Peking University.